Halper Sadeh Investigates Veritex, TaskUs, Y-mAbs Merger Activity

Halper Sadeh LLC is investigating Veritex Holdings, TaskUs, and Y-mAbs Therapeutics for potential violations of federal securities laws and breaches of fiduciary duties. The firm is looking into the sale of these companies to Huntington Bancshares, Blackstone, and SERB Pharmaceuticals, respectively. Shareholders of these companies are encouraged to click on the provided links to learn more about their legal rights and options.

Halper Sadeh LLC, an investor rights law firm, has initiated investigations into potential violations of federal securities laws and breaches of fiduciary duties by Veritex Holdings, TaskUs, and Y-mAbs Therapeutics. The firm is examining the proposed sales of these companies to Huntington Bancshares, Blackstone, and SERB Pharmaceuticals, respectively.

Veritex Holdings, Inc. (NASDAQ: VBTX), which is being sold to Huntington Bancshares Incorporated, has been the subject of investigation. The terms of the agreement include Huntington issuing 1.95 shares for each outstanding share of Veritex. Shareholders are encouraged to contact Halper Sadeh LLC to discuss their legal rights and options regarding this transaction [2].

TaskUs, Inc. (NASDAQ: TASK), which is being acquired by affiliates of Blackstone and executives and founders of TaskUs for $16.50 per share, is also under investigation. Shareholders of TaskUs are advised to contact Halper Sadeh LLC for more information on their legal rights and options [2].

Y-mAbs Therapeutics, Inc. (NASDAQ: YMAB), proposed to be sold to SERB Pharmaceuticals for $8.60 per share in cash, is also being scrutinized. Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC, have also expressed concerns about the adequacy of the consideration and the process leading to the proposed sale. Shareholders of Y-mAbs are encouraged to contact Halper Sadeh LLC for further details [1].

Halper Sadeh LLC may seek increased consideration for shareholders, additional disclosures, or other relief on behalf of shareholders. The firm is handling these actions on a contingent fee basis, meaning shareholders will not be responsible for out-of-pocket payment of legal fees or expenses [2].

Shareholders are advised to contact Halper Sadeh LLC free of charge to discuss their legal rights and options. The firm can be reached at (212) 763-0060 or via email at sadeh@halpersadeh.com or zhalper@halpersadeh.com.

References:
[1] https://www.globenewswire.com/news-release/2025/08/20/3136088/6713/en/Y-MABS-THERAPEUTICS-INVESTOR-ALERT-BY-THE-FORMER-ATTORNEY-GENERAL-OF-LOUISIANA-Kahn-Swick-Foti-LLC-Investigates-Adequacy-of-Price-and-Process-in-Proposed-Sale-of-Y-mAbs-Therapeutic.html
[2] https://www.globenewswire.com/news-release/2025/08/20/3136375/0/en/SHAREHOLDER-INVESTIGATION-Halper-Sadeh-LLC-Investigates-VBTX-TASK-YMAB-on-Behalf-of-Shareholders.html